{"id":"https://openalex.org/W2127901889","doi":null,"title":"An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.","display_name":"An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.","publication_year":2000,"publication_date":"2000-11-01","ids":{"openalex":"https://openalex.org/W2127901889","mag":"2127901889","pmid":"https://pubmed.ncbi.nlm.nih.gov/11085533"},"language":"en","primary_location":{"id":"pmid:11085533","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11085533","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068912186","display_name":"Michael R. McDevitt","orcid":"https://orcid.org/0000-0002-8855-0917","observed_orcids":["https://orcid.org/0000-0002-8855-0917"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M R McDevitt","raw_affiliation_strings":["Department of Pharmacology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021138558","display_name":"E Barendswaard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Barendswaard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005399548","display_name":"Dangshe Ma","orcid":"https://orcid.org/0000-0002-5919-6402","observed_orcids":["https://orcid.org/0000-0002-5919-6402"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Ma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075994642","display_name":"Lawrence T. Lai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Lai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111610177","display_name":"Michael J. Curcio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M J Curcio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113974155","display_name":"George Sgouros","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Sgouros","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020652593","display_name":"\u00c5se Ballangrud","orcid":"https://orcid.org/0000-0001-8269-8921","observed_orcids":["https://orcid.org/0000-0001-8269-8921"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A M Ballangrud","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023883029","display_name":"Wei\u2010Hsiung Yang","orcid":"https://orcid.org/0000-0002-2904-1143","observed_orcids":["https://orcid.org/0000-0002-2904-1143"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W H Yang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109031103","display_name":"Ronald D. Finn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R D Finn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050242419","display_name":"V Pellegrini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V Pellegrini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003844620","display_name":"Maurits W. Geerlings","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M W Geerlings","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"M Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108441025","display_name":"M W Brechbiel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M W Brechbiel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070626557","display_name":"Neil Harrison Bander","orcid":"https://orcid.org/0000-0003-4642-0759","observed_orcids":["https://orcid.org/0000-0003-4642-0759"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N H Bander","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080940311","display_name":"Carlos Cordon\u2010Cardo","orcid":"https://orcid.org/0000-0003-0858-5624","observed_orcids":["https://orcid.org/0000-0003-0858-5624"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Cordon-Cardo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5006680533","display_name":"David A. Scheinberg","orcid":"https://orcid.org/0000-0002-4160-923X","observed_orcids":["https://orcid.org/0000-0002-4160-923X","https://orcid.org/0009-0009-0651-7389"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D A Scheinberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":13.1981,"has_fulltext":false,"cited_by_count":258,"citation_normalized_percentile":{"value":0.99268893,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":100},"biblio":{"volume":"60","issue":"21","first_page":"6095","last_page":"100"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bismuth-213","display_name":"bismuth-213","score":0.8740000128746033},{"id":"https://openalex.org/keywords/alpha-particle-therapy","display_name":"alpha therapy","score":0.7379999756813049},{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"radioimmunotherapy","score":0.9290000200271606},{"id":"https://openalex.org/keywords/prostate-specific-membrane-antigen","display_name":"prostate-specific membrane antigen","score":0.847000002861023},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.8600000143051147},{"id":"https://openalex.org/keywords/lncap-cells","display_name":"LNCaP cells","score":0.7720000147819519},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.7450000047683716},{"id":"https://openalex.org/keywords/prostate-specific-antigen","display_name":"prostate-specific antigen","score":0.6600000262260437},{"id":"https://openalex.org/keywords/radiolabeled-antibodies","display_name":"radiolabeled antibodies","score":0.42399999499320984},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.3580000102519989},{"id":"https://openalex.org/keywords/tumor-free-survival","display_name":"tumor-free survival","score":0.5699999928474426},{"id":"https://openalex.org/keywords/alpha-particle-range","display_name":"alpha particle range","score":0.32600000500679016}],"concepts":[{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.8618520498275757},{"id":"https://openalex.org/C2779723316","wikidata":"https://www.wikidata.org/wiki/Q6459234","display_name":"LNCaP","level":4,"score":0.8272284269332886},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6251422762870789},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6165415644645691},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5743154883384705},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5631569623947144},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5012822151184082},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.45589473843574524},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.42043018341064453},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3683340549468994},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.275967001914978},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2216830551624298},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1749235987663269},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14079800248146057},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09472289681434631},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000512","descriptor_name":"Alpha Particles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000922","descriptor_name":"Immunotoxins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000922","descriptor_name":"Immunotoxins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000922","descriptor_name":"Immunotoxins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000936","descriptor_name":"Antigen-Antibody Complex","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001729","descriptor_name":"Bismuth","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":true},{"descriptor_ui":"D011868","descriptor_name":"Radioisotopes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013379","descriptor_name":"Substrate Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016499","descriptor_name":"Radioimmunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016923","descriptor_name":"Cell Death","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false},{"descriptor_ui":"D018874","descriptor_name":"Spheroids, Cellular","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11085533","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11085533","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:2127901889","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11085533","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2482401937","display_name":"Improving specificity of therapeutic antibodies for cancer.","funder_award_id":"R01CA055349","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1523096697","https://openalex.org/W1597864572","https://openalex.org/W1982852535","https://openalex.org/W2043319149","https://openalex.org/W2043882164","https://openalex.org/W2070055506","https://openalex.org/W2072475957","https://openalex.org/W2080585386","https://openalex.org/W2088283955","https://openalex.org/W2097629605","https://openalex.org/W2098301610","https://openalex.org/W2101581671","https://openalex.org/W2123987346","https://openalex.org/W2134247556","https://openalex.org/W2156115176","https://openalex.org/W2162292616","https://openalex.org/W2168001271","https://openalex.org/W2347139417","https://openalex.org/W2405785190","https://openalex.org/W2418291002","https://openalex.org/W2440288526","https://openalex.org/W2463381696","https://openalex.org/W2748281654"],"related_works":["https://openalex.org/W2165199733","https://openalex.org/W1986689451","https://openalex.org/W1963575875","https://openalex.org/W2463670839","https://openalex.org/W2028392455","https://openalex.org/W2240315679","https://openalex.org/W2088438005","https://openalex.org/W3108377814","https://openalex.org/W2241372383","https://openalex.org/W2254095073"],"abstract_inverted_index":{"A":[0],"novel":[1,314],"alpha-particle":[2],"emitting":[3],"monoclonal":[4,35],"antibody":[5,36],"construct":[6],"targeting":[7],"the":[8,40,102,110,113,170],"external":[9],"domain":[10],"of":[11,63,88,125,134,141,161,169,194,282],"prostate-specific":[12],"membrane":[13],"antigen":[14,229],"(PSMA)":[15],"was":[16,31,106,117,127,155,198,231,300],"prepared":[17],"and":[18,22,74,139,267,296,306,330,335],"evaluated":[19],"in":[20,23,148,179,184,211,235,285,333,336],"vitro":[21,149,334],"vivo.":[24,337],"The":[25,77,122,137,280],"chelating":[26],"agent,":[27],"N-[2-amino-3-(p-isothiocyanatophen-yl)propyl]-trans-cyclohexane-1,":[28],"2-diamine-N,N',N',N'',N''-pentaacetic":[29],"acid,":[30],"appended":[32],"to":[33,37,70,94,120,165,200,215,291,324],"J591":[34,92,316],"stably":[38],"bind":[39],"213Bi":[41],"radiometal":[42,114],"ion.":[43],"Bismuth-213":[44],"is":[45],"a":[46,97,131,313],"short-lived":[47],"(t":[48],"1/2":[49],"=":[50,251,261,274],"46":[51],"min)":[52],"radionuclide":[53],"that":[54,66,320],"emits":[55],"high":[56],"energy":[57],"alpha-particles":[58,323],"with":[59,96,190,217,265,278,288,294,302],"an":[60,84,147,166,185,191],"effective":[61],"range":[62],"0.07-0.10":[64],"mm":[65],"are":[67],"ideally":[68],"suited":[69],"treating":[71],"single-celled":[72],"neoplasms":[73],"micrometastatic":[75,152],"carcinomas.":[76],"LNCaP":[78,145,162,195],"prostate":[79,325],"cancer":[80,326],"cell":[81],"line":[82],"had":[83],"estimated":[85],"180,000":[86],"molecules":[87],"PSMA":[89,95],"per":[90],"cell;":[91],"bound":[93],"3-nM":[98],"affinity.":[99],"After":[100],"binding,":[101],"radiolabeled":[103],"construct-antigen":[104],"complex":[105],"rapidly":[107],"internalized":[108],"into":[109],"cell,":[111],"carrying":[112],"inside.":[115],"[213Bi]J591":[116,126,142,157,197,289],"specifically":[118,233],"cytotoxic":[119],"LNCaP.":[121],"LD50":[123],"value":[124],"220":[128],"nCi/ml":[129],"at":[130],"specific":[132,331],"activity":[133],"6.4":[135],"Ci/g.":[136],"potency":[138],"specificity":[140],"directed":[143],"against":[144],"spheroids,":[146],"model":[150,189],"for":[151,328],"cancer,":[153],"also":[154,232],"investigated.":[156],"effectively":[158],"stopped":[159],"growth":[160],"spheroids":[163],"relative":[164,214,290],"equivalent":[167],"dose":[168],"irrelevant":[171,218],"control":[172,219,298],"[213Bi]HuM195":[173,220,295],"or":[174,223],"unlabeled":[175],"J591.":[176],"Cytotoxicity":[177],"experiments":[178,213],"vivo":[180],"were":[181,244],"carried":[182],"out":[183],"athymic":[186],"nude":[187],"mouse":[188],"i.m.":[192],"xenograft":[193],"cells.":[196],"able":[199],"significantly":[201],"improve":[202],"(P":[203],"<":[204,304,308],"0.0031)":[205],"median":[206],"tumor-free":[207],"survival":[208],"(54":[209],"days)":[210],"these":[212],"treatment":[216,225],"(33":[221],"days),":[222],"no":[224],"(31":[226],"days).":[227],"Prostate-specific":[228],"(PSA)":[230],"reduced":[234],"treated":[236,264,277,287,293],"animals.":[237],"At":[238],"day":[239],"51,":[240],"mean":[241],"PSA":[242,283],"values":[243],"104":[245],"ng/ml":[246,249,256,259,269,272],"+/-":[247,257,270],"54":[248],"(n":[250,260,273],"4,":[252],"untreated":[253,297],"animals),":[254],"66":[255],"16":[258],"6,":[262,275],"animals":[263,276,299],"[213Bi]HuM195),":[266],"28":[268],"22":[271],"[213Bi]J591).":[279],"reduction":[281],"levels":[284],"mice":[286,292],"significant":[301],"P":[303,307],"0.007":[305],"0.0136,":[309],"respectively.":[310],"In":[311],"conclusion,":[312],"[213Bi]-radiolabeled":[315],"has":[317],"been":[318],"constructed":[319],"selectively":[321],"delivers":[322],"cells":[327],"potent":[329],"killing":[332]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":15}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}